Prophylix AS
Company

Prophylix AS

Biotechnology Research Tromso, Troms Og Finnmark, No 6 employees
Employees
6

Prophylix AS Overview

Headquarters
Tromso, Troms Og Finnmark, No
Industry
Biotechnology Research
Employees
6
Founded
2008
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Prophylix AS

Prophylix AS is a Norwegian biotech company developing orphan drugs for the prevention of life-threatening or chronically disabling intracranial bleeding in fetuses due to fetal and neonatal alloimmune thrombocytopenia (FNAIT). The lead drug NAITgam contains specific IgG antibodies derived from plasma donated by women with a history of FNAIT in their fetus or newborn. The NAITgam is developed within the frames of the EU-supported PROFNAIT project, read more at: www.profnait.eu

Compare Similar Companies to Prophylix AS